|

Sonesitatug vedotin Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AZD0901

Pipeline

Phase 3: 1

Top Sponsors

  • AstraZeneca1

Indications

  • Gastroesophageal Junction Adenocarcinoma1
  • Gastric Cancer1
  • Esophageal Cancer1
  • Cancer1

Phoenix, Arizona1 trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.